CRNX
Crinetics Pharmaceuticals, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Crinetics Pharmaceuticals, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last report1 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+0.12%
vs ±1.1% implied · ×0.11
shaded = implied · ▲▼ = realized
No thesis.
Largest filed tie
—
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | FMRFMR | $592.7M | 12.80% | +0.51% | |
| 2 | BlackRockBlackRockindex-like | $365.2M | 7.89% | +15.10% | |
| 3 | Farallon Capital ManagementFarallon | $336.4M | 7.26% | +7.81% | |
| 4 | Wellington Management GroupWellington | $266.8M | 5.76% | −12.58% | |
| 5 | Driehaus Capital ManagementDriehaus | $241.9M | 5.22% | +1.06% | |
| 6 | T. Rowe Price AssociatesT. Rowe Price | $232.5M | 5.02% | +16.01% | |
| 7 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $180.8M | 3.91% | +4.18% | |
| 8 | Vanguard Capital ManagementVanguardindex-like | $177.6M | 3.83% | +1.53% | |
| 9 | Jupiter TopcoJupiter Topco | $170.5M | 3.68% | — | |
| 10 | Geode Capital ManagementGeodeindex-like | $102.1M | 2.20% | +9.95% | |
| 11 | State StreetState Streetindex-like | $100.6M | 2.17% | +11.91% | |
| 12 | Bellevue GroupBellevue | $98.0M | 2.12% | −20.12% | |
| 13 | Baker Bros. AdvisorsBaker Bros. | $88.0M | 1.90% | 0.00% | |
| 14 | Polar Capital HoldingsPolar Capital | $85.1M | 1.84% | new | |
| 15 | Pictet Asset Management HoldingPictet | $77.6M | 1.68% | +10.14% | |
| 16 | T. Rowe Price Investment ManagementT. Rowe Price | $75.2M | 1.62% | +3.59% | |
| 17 | GW&K Investment ManagementGW&K | $64.8M | 1.40% | +6.95% | |
| 18 | BNP Paribas Investment PartnersBNP Paribas Investment Partners | $62.8M | 1.36% | −2.21% | |
| 19 | SirenSiren | $53.2M | 1.15% | −25.36% | |
| 20 | First Light Asset ManagementFirst Light | $50.9M | 1.10% | +24.89% | |
| 21 | JPMorgan ChaseJPMorgan Chase | $50.6M | 1.09% | +3.05% | |
| 22 | Morgan StanleyMorgan Stanley | $50.1M | 1.08% | +45.54% | |
| 23 | Bank of AmericaBank of America | $49.9M | 1.08% | +86.15% | |
| 24 | NovoNovo | $49.4M | 1.07% | −14.84% | |
| 25 | Dimensional Fund AdvisorsDimensional | $47.5M | 1.03% | +49.08% |
261 managers report $4.6B of Crinetics Pharmaceuticals on form 13F for the quarter ended Jun 30 '26. 26 of them hold 80% of it; FMR is largest at 12.80%.
No implied move.
No implied move.
Expected move
No implied move.
Crinetics Pharmaceuticals, Inc.
84.97
+0.13 · +0.15%
post 84.97 0.00%